kanamycin a has been researched along with azlocillin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, DH; Lu, CD | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Bayer, AS; Kim, KS | 1 |
| Gaya, H; Glauser, MP; Klastersky, J; Schimpff, SC; Zinner, SH | 1 |
| Johnson, DE; Thompson, B | 1 |
| Balischewski, B; Kiessig, R; Köditz, H; Thal, W | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR | 1 |
| Boulton Jones, JM; Gribben, J; Leung, AC; Sleigh, JD | 1 |
| Gerding, DN; Moody, JA; Peterson, LR | 1 |
| Barry, AL; Gavan, TL; Jones, RN; Thornsberry, C | 1 |
1 trial(s) available for kanamycin a and azlocillin
| Article | Year |
|---|---|
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Cefotaxime; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kanamycin; Male; Middle Aged; Penicillins; Prospective Studies; Random Allocation; Regression Analysis; Sepsis; Ticarcillin | 1986 |
11 other study(ies) available for kanamycin a and azlocillin
| Article | Year |
|---|---|
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Azlocillin; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Kanamycin; Penicillin Resistance; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Time Factors | 1986 |
Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Topics: Agranulocytosis; Amikacin; Animals; Azlocillin; Drug Therapy, Combination; Female; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillin Resistance; Penicillins; Pseudomonas Infections; Rats; Rats, Inbred Strains; Sepsis; Ticarcillin | 1986 |
[Antibacterial activities of amicacin, azlocillin and cefotaxim in bronchial secretion and serum of children].
Topics: Amikacin; Anti-Infective Agents; Azlocillin; Bronchi; Cefotaxime; Child; Humans; Kanamycin; Penicillins | 1983 |
Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
Topics: Agranulocytosis; Amikacin; Animals; Anti-Bacterial Agents; Azlocillin; Cefotaxime; Cefoxitin; Ceftizoxime; Disease Models, Animal; Drug Combinations; Female; Hydrogen-Ion Concentration; Kanamycin; Microbial Sensitivity Tests; Neutropenia; Penicillins; Protein Binding; Pseudomonas Infections; Rabbits | 1984 |
Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
Topics: Amikacin; Azlocillin; Female; Humans; Kanamycin; Middle Aged; Penicillin Resistance; Penicillins; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections | 1983 |
In vitro activities of ureidopenicillins alone and in combination with amikacin and three cephalosporin antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Azlocillin; Bacteria; Cephalosporins; Drug Interactions; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa | 1984 |
In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides.
Topics: Amikacin; Ampicillin; Azlocillin; Bacteria; Carbenicillin; Gentamicins; Kanamycin; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Ticarcillin | 1980 |